Drug Trial Radar · NCT06106672
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis
Last checked: Nov 20, 2026Latest source record: Jun 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
54
Planned (sponsor's estimate)
Start
May 30, 2024
Primary completion
Jun 2026
Study completion Aug 2026
Sponsor
- Lead sponsor
- COUR Pharmaceutical Development Company, Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 30, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-106.
Conditions
- Myasthenia Gravis
- Generalized Myasthenia
- AChR Myasthenia Gravis
- MuSK MG
Interventions
CNP-106Drug
CNP-106 is comprised of an antigenic AChR Peptide Pool (\~1 μg of each AChRα and AChRε peptide comprising AChR Peptide Pool Drug Substance per mg particles) dispersed within a negatively charged (-30 to -60 mV) polymer matrix of PLGA (Poly (DL-lactide-co-glycolide, 50:50 acid-end group)) particles (400-800 nm in size).
PlaceboOther
CNP-106 Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency of Adverse Events (AEs) and Serious Adverse Events (SAEs),Time frame: Through study day 180
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Barrow Neurological Institute
Phoenix, Arizona
Infusion for Health
Brea, California
University of California, Irvine
Orange, California
University of California, Davis
Sacramento, California
Yale University
New Haven, Connecticut
Atlantis Research
Miami, Florida
Quantix Research, LLC
Miami, Florida
University of South Florida
Tampa, Florida
Insight Hospital and Medical Center
Chicago, Illinois
University of Kansas Medical Center
Kansas City, Kansas
Insight Research Institute, Dearborn
Dearborn, Michigan
University of Missouri, NextGen Precision Health
Columbia, Missouri
Ohio State University Wexner Medical Center
Colombus, Ohio
Medical University of South Carolina
Charleston, South Carolina
Nerve and Muscle Center of Texas
Houston, Texas
Prolato Clinical Research Center
Houston, Texas
Virginia Commonwealth University
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.